Nov 04, 2021 / NTS GMT
Spencer Israel - Benzinga - Moderator
Hey, everybody. Did you miss me? I know, long time no see, I'm back. Good to see you guys.
Spencer Israel here with another addition of Benzinga All Access. So reminder, what is this show? It's a show where we don't talk about stocks, right? We don't talk about the market.
We don't talk about even an individual company stock, whether it can go up or down or sideways. We don't really care about that for the purposes of the show, we do enough of that on every other show. The purpose of All Access, what I always tell people, and I tell our guests this as well, I can tell to you guys is think about a scale between Investor presentation over here and podcast conversation over here, and we're right in the middle of that, right in the middle of that scale, right?
It's not like a super formal stuff Investor presentation, and it's also not quite in the same super casual, super long-form format as it go. An hour long, hour-15-minute-long podcast interview, but it is somewhere in the middle.
The point of this show is to get access to company
Pressure Biosciences Inc At Benzinga ALL ACCESS Investor Event Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
